Fritextsökning
Artiklar per år
Innehållstyper
-
Hallå där Martin Vidaeus,
marknadschef på kontraktstillverkaren Unitech Pharma, som just fått utökat tillstånd att tillverka aseptiskt läkemedel...
-
Bioinvent inleder fas II-studie
Bolagets blodproppspreparat ska testas på knäoperationspatienter.
-
Helge Sander: "Fler kvinnor behövs"
- Det är något fel när det ena könet i stort sett väljer bort en karriär som forskare, säger Danmarks forskningsminister. Idag håller han rundabordssamtal för att diskutera varför kvinnliga forskare missgynnas. Han välkomnar alla lösningar, utom en.
-
Svenska chefer stryper forskningen
Färre forskare nyanställs och den befintliga forskningsstyrkan kan minskas. Det visar en ny rapport som bygger på svar från knappt trehundra chefer i svenska innovationsföretag.
-
Han blir Alphahelix nya VD
Bolagets tidigare teknikchef tar ett steg upp.
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at approximately $68 billion. The Boards of Directors of both companies have said yes to the deal that may lead to lay-offs of some 8,000 persons.
-
Almost 150 will leave Coloplast
The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Danish biorefinery can save US billions
The Danish Inbicon biorefinery process could save the US billions on foreign oil, the organization states.
-
Cancer cells cheat suicide call
Cancer cells cheat death by reversing a process which causes normal cells to commit suicide at the end of their natural life, researchers from the University of Hong Kong have shown.
-
Ambassador program makes MVA big in Japan
The first ambassadors of the Medicon Valley Ambassador Programme have only worked in each other's countries for six months. But they have already made a significant difference for their sister clusters.